Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E.C. Riley
Cosmetic Outcome and Quality of Life of Patients Undergoing Once Weekly Hypofractionated Breast Irradiation (WHBI): Interim Analysis of an Institutional Phase II Trial
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Second Conservative Treatment for Breast Cancer Local Recurrence Using HDR Interstitial Brachytherapy: Cosmetic Outcome and Quality of Life
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Recommendations for Hypofractionated Whole-Breast Irradiation
Revista da Associacao Medica Brasileira
Medicine
Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial
Current Medical Research and Opinion
Medicine
Improved Treatment Satisfaction and Weight-Related Quality of Life With Exenatide Once Weekly or Twice Daily
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Determinants of Quality of Life in Patients With Breast Cancer Undergoing External Beam Radiotherapy
Archives of Medical Science
Medicine
A Phase II Study of Once a Day Partial Breast Irradiation (PBI) for Early-Stage or Noninvasive Breast Cancer: Early Toxicity Outcomes
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
Multicenter Phase II Study With Weekly Bendamustine and Paclitaxel as First- Or Later-Line Therapy in Patients With Metastatic Breast Cancer: RiTa II Trial
Breast Care
Surgery
Oncology
